The TP53 gene is one of the most frequently deregulated genes in cancer [17], particularly in gliomas, and protein 53 is a central part in the TP53/MDM2/MDM4 pathway, which becomes active in response to DNA damage or other cellular changes. This evidence concerns the gene MDM2 and glioma.